Now one of the mainstays of cardiac imaging, PET offers undeniably better imaging and diagnostic potential. When paired with N-13 Ammonia, the value of PET grows even clearer.
With a low positron range and excellent extraction and retention, N-13 Ammonia paves the way to better diagnostics with high sensitivity and overall accuracy for detecting CAD.* The result is better risk classification and overall patient management.
Providing high diagnostic accuracy in both male and female patients as well as overweight and obese patients, N-13 Ammonia is used in a growing number of major academic institutions and is rapidly changing the standard of excellence for PET imaging.
While PET/MPI is widely viewed to be superior to SPECT, not all tracers are equal. Considered an optimal tracer for Myocardial Perfusion, N-13 Ammonia provides1
1. Fiechter et al., J Nucl Med 2012; 53: 1230-1234
Difficult cases call for different thinking and solutions. In many instances, N-13 Ammonia PET-MPI is the answer.
Thanks to a longer half-life, N-13 Ammonia allows for testing options not possible with other FDA-approved tracers.
For example, N-13 Ammonia allows for patients to be treadmill exercised as an alternative to pharmacologic stress.
Recent studies utilizing treadmill N-13 Ammonia stress testing have demonstrated:
|Physical properties 2||N-13 Ammonia||Rb-82 Cl|
|Half life (min)||9.97||1.27|
|Positron range (mm)||0.57||2.60|
|Image Resolution (mm) FWHM||5||8|
|Effective radiation (mSv/MBq)||0.002||0.0034|
|Raw material||High Purity O-16 water and methane gas||Sr-82/Sr-85|
|Physiological properties 1||Ammonia N-13||Rb-82 Cl|
Reimbursement is critical to the financial viability of any cardiac PET program. N-13 Ammonia is FDA-approved, fully reimbursed by Medicare and private payers. Plus, IONETIX stands ready to help you navigate the reimbursement process so you can focus on what you do best: delivering the best care possible.
INDICATIONS AND USAGE
N-13 Ammonia Injection is a radioactive diagnostic agent for Positron Emission Tomography (PET) indicated for diagnostic PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease.
No adverse reactions have been reported for N-13 Ammonia Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting system.
WARNINGS AND PRECAUTIONS
N-13 Ammonia Injection may increase the risk of cancer. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker.